(R)-((Z)-2-propenyl)pyrrolidine-1-carboxylic acid tert-butyl ester | 868286-65-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 英文名称: (R)-((Z)-2-propenyl)pyrrolidine-1-carboxylic acid tert-butyl ester
• 英文别名: tert-butyl-(2R)-2-[(1Z)-prop-1-enyl]pyrrolidine-1-carboxylate；tert-butyl (2R)-2-[(Z)-prop-1-enyl]pyrrolidine-1-carboxylate
• CAS: 868286-65-1
• 化学式: C₁₂H₂₁NO₂
• 分子量: 211.304
• InChiKey: KOJWLBLXDVVJHG-BXKUYDPTSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  29.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  1-Boc-四氢吡咯 在 仲丁基锂 、 zinc(II) chloride 、 鹰爪豆碱 作用下， 以 乙醚 、 甲基叔丁基醚 、 环己烷 为溶剂， 反应 19.5h， 生成 (R)-((Z)-2-propenyl)pyrrolidine-1-carboxylic acid tert-butyl ester
  参考文献：
  名称：

  N -Boc吡咯烷的对映选择性，钯催化的α-芳基化：原位反应红外光谱监测，范围和合成应用

  摘要：

  已对N - Boc吡咯烷的对映选择性Pd催化的α-芳基化进行了全面研究。该方案包括在-78°C的条件下在TBME或Et 2 O中使用s -BuLi /（-）-天冬氨酸对N -Boc吡咯烷进行质子化，ZnCl 2的金属转移和使用Pd（OAc）2，t -Bu 3 P的Negishi偶联-HBF 4和芳基溴化物。本文报告了一些新功能，包括原位反应红外光谱监测过程；使用（-）-partaine和（+）-sparteine代理访问具有相反配置的产品；催化不对称锂化-Negishi偶联反应的发展；扩展到广泛的杂芳族溴化物；（R）-crispine A，（S）-尼古丁和（S）-SIB-1508Y通过短合成路线的全合成；以及使用乙烯基溴的N -Boc吡咯烷的α-乙烯基化的例子，其示例为天然存在的（+）-maackiamine的全合成（因此将其构型确定为（R））。以这种方式，描述了该方法的全部范围和局限性。

  DOI：

  10.1021/jo2011347

文献信息

• [EN] 1,3,5-SUBSTITUTED PHENYL DERIVATIVE COMPOUNDS USEFUL AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE<br/>[FR] DERIVES DE PHENYLE 1,3,5-SUBSTITUES UTILES COMME INHIBITEURS DE LA BETA-SECRETASE POUR LE TRAITEMENT DE LA MALADIE D'ALZHEIMER
  申请人：MERCK & CO INC

  公开号：WO2005103020A1

  公开（公告）日：2005-11-03

  The present invention is directed to 1,3,5-phenyl substituted derivative compounds which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of such diseases in which the beta-secretase enzyme is involved.

  本发明涉及1,3,5-苯基取代衍生物化合物，这些化合物是β-分泌酶的抑制剂，可用于治疗β-分泌酶参与的疾病，例如阿尔茨海默病。该发明还涉及包含这些化合物的药物组合物，以及这些化合物和组合物在治疗β-分泌酶参与疾病中的用途。
• Simple Chiral Diaminobinaphthyl Dilithium Salts for Intramolecular Catalytic Asymmetric Hydroamination of Amino-1,3-dienes
  作者：Julia Deschamp、Clarisse Olier、Emmanuelle Schulz、Régis Guillot、Jérôme Hannedouche、Jacqueline Collin

  DOI：10.1002/adsc.201000302

  日期：2010.9.10

  Simple and easily accessible chiral lithium amide salts are reported as efficient (pre)catalysts for the diastereo‐ [up to (E:Z)=92:8] and enantioselective [up to 72% ee (E)] hydroamination/cyclisation of conjugated primary aminodienes. These chiral lithium salts are straightforwardly prepared by in situ combination of an N‐substituted (R)‐(+)‐1,1′‐binaphthyl‐2,2′‐diamine ligand and a commercial methyllithium

  据报道，简单，容易获得的手性锂酰胺盐是共轭化合物的非对映异构体[高达（E：Z）= 92：8]和对映选择性[高达72％ee（E）]的高效（预）催化剂。伯氨基二烯。这些手性锂盐是通过原位结合N-取代的（R）-（+）-1,1'-联萘-2-2,2'-二胺配体和市售的甲基锂溶液直接制备的。这些盐的固态结构信息是通过单晶的X射线分析获得的。
• 1,3,5-Substituted Phenyl Derivative Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
  申请人：Barrow C. James

  公开号：US20070244119A1

  公开（公告）日：2007-10-18

  The present invention is directed to 1,3,5-phenyl substituted derivative compounds which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of such diseases in which the beta-secretase enzyme is involved.

  本发明涉及一类1,3,5-苯基取代衍生物化合物，它们是β-分泌酶酶的抑制剂，可用于治疗β-分泌酶酶参与的疾病，如阿尔茨海默病。本发明还涉及包含这些化合物的制药组合物，以及这些化合物和组合物在治疗β-分泌酶酶参与的疾病中的用途。
• 1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's disease
  申请人：Merck, Sharp & Dohme, Inc.

  公开号：US07847100B2

  公开（公告）日：2010-12-07

  The present invention is directed to 1,3,5-phenyl substituted derivative compounds which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of such diseases in which the beta-secretase enzyme is involved.

  本发明涉及1,3,5-苯基取代衍生物化合物，其是β-分泌酶酶的抑制剂，并且在治疗β-分泌酶酶参与的疾病中，例如阿尔茨海默病，具有用途。该发明还涉及包含这些化合物的制药组合物，以及在治疗β-分泌酶酶参与的疾病中使用这些化合物和组合物的方法。
• 1,3,5-SUBSTITUTED PHENYL DERIVATIVE COMPOUNDS USEFUL AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
  申请人：Merck Sharp & Dohme Corp.

  公开号：EP1740559B1

  公开（公告）日：2014-10-15